Evidence map›Paper›PMID 41263685›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2025

A Pathogen Selection Tool for Surveillance of Acute Febrile Illness in Nigeria.

Lauren P Courtney, Claire A Quiner, Cyril Erameh, Vivian Kwaghe, Jean H Kim, Jay Osi Samuels, Claire J Standley, Emmanuel A Oga

Abstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. High Burden of Coinfections With Epidemic-Prone Pathogens Among Febrile Patients in Nigeria: A Multi-Pathogen Surveillance Study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2025
    Article
  2. Multi-Pathogen Surveillance of Acute Febrile Illness in Nigeria Using TaqMan Array Cards: Implementation Successes and Lessons Learned From the SAFIAN Study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2025
    Article
  3. Article
  4. Design and Implementation of a One Health Framework for Evaluating the Transmission Potential of Pathogens of Public Health Interest for Surveillance Studies.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Lauren P CourtneySolutions, RTI International, Durham, North Carolina, USA.ORCID 0000-0002-8943-4934
Claire A QuinerSolutions, RTI International, Durham, North Carolina, USA.ORCID 0000-0003-4419-1542
Cyril EramehInstitute of Viral and Emergent Pathogens Control and Research, Irrua Specialist Teaching Hospital, Irrua, Nigeria.ORCID 0000-0001-7783-2495
Vivian KwagheInternal Medicine, University of Abuja Teaching Hospital, Gwagwalada, Federal Capital Territory, Nigeria.ORCID 0000-0003-1962-4641
Jean H KimSolutions, RTI International, Durham, North Carolina, USA.ORCID 0000-0002-2207-6263
Jay Osi SamuelsLaboratory Services, APIN Public Health Initiative, Nigeria.ORCID 0000-0001-8933-1006
Claire J StandleyCenter for Global Health Science and Security, Georgetown University, Washington, District of Columbia, USA.ORCID 0000-0002-4291-9723
Emmanuel A OgaSolutions, RTI International, Durham, North Carolina, USA.ORCID 0000-0002-0744-5681

Funding

Department of Defense, Defense Threat Reduction Agency HDTRA12210019
6 · The paper itself

Abstract

backgroundAcute febrile illness (AFI) is a common manifestation of infectious diseases and a frequent reason for seeking medical care. Because AFI is a likely clinical presentation of several infectious diseases of public health significance, inadequate diagnostic capacity can delay outbreak detection and response. The Surveillance of Acute Febrile Illness Aetiologies in Nigeria (SAFIAN) study aimed to investigate the infectious causes of AFI in Nigeria.

methodsWe used a TaqMan Array Card (TAC) technology, one of several commercially available tools based on reverse-transcription polymerase chain reaction, which can be customized for simultaneous detection of multiple pathogens. Researchers must prioritize pathogens to target for surveillance, given that it is not feasible or cost-effective to test all pathogens endemic in a region.

resultsWe developed a 6-step model for pathogen selection for AFI surveillance studies. These 6 steps included (1) defining the study objectives; (2) identifying a global list of potential pathogens compatible with study objectives; (3) evaluating transmission potential of selected pathogens in region(s) of interest; (4) defining the pathogen inclusion and exclusion criteria based on surveillance interests; (5) applying inclusion and exclusion criteria to rank pathogen importance based on evidence of endemicity or alignment with surveillance interest; and (6) selecting the final list of pathogens for surveillance. Using this model, we identified and evaluated 69 potential pathogens and customized a TAC panel with 25 targets.

conclusionsDespite the lack of external feedback, we posit that this model for pathogen selection can be applied to future AFI surveillance studies in resource-constrained settings.This article presents a 6-step, data-driven framework for optimizing multi-pathogen screening tools, aligning pathogen selection with transmission potential. The adaptable, user-friendly tool enhances surveillance in low-resource settings, supporting early outbreak detection and response before widespread transmission occurs.

Indexed as

Communicable DiseasesEpidemiological MonitoringFeverAcute DiseaseHumansNigeriaPopulation Surveillanceacute febrile illness (AFI)infectious disease surveillancepathogen selectionTaqMan array card

Identifiers

PMID41263685
PMCPMC12631781

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.